ROCKETVAX
RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.
ROCKETVAX
Industry:
Biotechnology Chemical Health Care Life Science Pharmaceutical
Founded:
2020-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.rocketvax.com
Total Employee:
11+
Status:
Active
Contact:
+41-615-615-421
Email Addresses:
[email protected]
Total Funding:
9.2 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag Mobile Non Scaleable Content
Similar Organizations
ARNA Genomics
ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Current Advisors List
Current Employees Featured
Founder
Investors List
University Hospital Basel
University Hospital Basel investment in Grant - RocketVax
Canton of Basel-Stadt
Canton of Basel-Stadt investment in Grant - RocketVax
InnoSuisse
InnoSuisse investment in Grant - RocketVax
Official Site Inspections
http://www.rocketvax.com
- Host name: 159.223.2.56
- IP address: 159.223.2.56
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RocketVax"
RocketVax - Crunchbase Company Profile & Funding
Organization. RocketVax . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ...See details»
Rocketvax AG - LinkedIn
RocketVax has its foundation in the ties between Swiss Rockets AG, a Swiss incubator and accelerator for startups with innovative therapies, and a team of expert scientists from the …See details»
RocketVax Company Profile 2024: Valuation, Funding & Investors
RocketVax General Information Description. Developer of a vaccine designed to stop the spread of SARS-CoV-2. The company uses a digital DNA design platform to develop a vaccine that …See details»
RocketVax - EU-Startups
RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology. It is is a Swiss biotech startup based in Basel and was established in …See details»
RocketVax - Funding, Financials, Valuation & Investors - Crunchbase
RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology. Search Crunchbase. Start Free Trial . Chrome Extension. ... How …See details»
Rocketvax AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Rocketvax AG of Basel, BASEL-STADT. Get the latest business insights from Dun & Bradstreet.See details»
RocketVax has successfully completed another round of ... - LinkedIn
Feb 8, 2023 RocketVax AG successfully concluded a financing round with renowned and experienced investors at the end of 2022. The lead investor is the Wietlisbach Foundation. …See details»
Rocketvax AG selected to participate in SIX Swiss Exchange
Nov 15, 2023 Rocketvax AG announces its participation in the Sparks IPO Academy by the SIX Swiss Exchange, beginning with the kick-off event on 30 October 2023. This selection initiates …See details»
RocketVax AG Announces New Milestones in the Development of …
Sep 23, 2022 RocketVax has its foundation in the ties between Swiss Rockets AG, a Swiss incubator and accelerator for startups with innovative therapies, and a team of expert …See details»
Swiss Rockets AG announces the founding of ROCKETVAX for the ...
Nov 10, 2020 RocketVax works together with leading scientists. Prof. Marcel Tanner, Emeritus Professor of Epidemiology, Medical Parasitology and Public Health and former Director of the …See details»
Swiss Rockets AG kündigt die Gründung von ROCKETVAX
Nov 10, 2020 RocketVax arbeitet mit führenden Wissenschaftler/innen zusammen. Prof. Marcel Tanner, emeritierter Professor für Epidemiologie, medizinische Parasitologie und …See details»
RocketVax | EU-Startups
At RocketVax, they use a proprietary based method to develop new groundbreaking vaccines. Their first product was the RVX-13, an alive, single-cycle vaccine against SARS-CoV-2, which …See details»
Rocketvax Announces Collaboration with the US National
BASEL, 13 June 2024 – Rocketvax AG, a biotech company focused on developing next-generation live-attenuated viral vaccines, today announced that its RVX-sCPD9 candidate for …See details»
Swiss Rockets AG announces the founding of ROCKETVAX for the ...
Nov 10, 2020 RocketVax works together with leading scientists. Prof. Marcel Tanner, Emeritus Professor of Epidemiology, Medical Parasitology and Public Health and former Director of the …See details»
Un vaccin suisse anti-covid en développement à Bâle lève ... - Le …
Créée en 2020, la société bâloise RocketVax vient d’obtenir un financement pour lancer la phase préclinique du développement de son vaccin contre le covid. Pour se démarquer, la jeune …See details»
Rocketvax AG – Swiss Biotech
Altamira Therapeutics is developing and supplying peptide-based nanoparticles for efficient RNA delivery to extrahepatic tissues. Our versatile OligoPhore™ and SemaPhore™ platforms are …See details»
RocketVax Nasal Vaccine to Prevent COVID-19 Passes First Tests
Apr 5, 2023 RocketVax was established through a collaboration between Swiss Rockets AG, a Swiss-based incubator and accelerator for startups focusing on innovative therapies, and a …See details»
RocketVax - Company Profile - Tracxn
Nov 16, 2024 RocketVax ranks 34th among 127 active competitors. 34 of its competitors are funded while 15 have exited. Overall, RocketVax and its competitors have raised over $1.94B …See details»
Swiss Rockets AG announces the founding of ROCKETVAX for the ...
Nov 10, 2020 /PRNewswire/ -- The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. A Basel-based subsidiary,...See details»
New study on the benefits of Rocketvax COVID-19 nasal spray
Feb 29, 2024 Rocketvax AG, together with the German Research Foundation (DFG), has financially supported a study carried out as part of a joint project of the Swiss National Science …See details»